affordable

06/17/2019

IVI partners with QuadMedicine to develop microneedle-based vaccines

Dr. Jerome Kim (left), General Director of IVI and Mr. Seung-Ki Baek, CEO of QuadMedicine   June 17, 2019 – SEOUL, South Korea. Today IVI exchanged a memorandum of understanding with QuadMedicine, a Korea-based biotech venture, to collaborate on the development of microneedle-based vaccines. With […]
07/10/2019

Seminar: Towards Affordable Conjugate Vaccines: Efficient Chemistry, Affordable CRM197 Carrier Protein and Supporting New Entrants

Dr. Andrew Lees, Scientific Director of Fina BioSolutions LLC, giving a seminar at IVI   July 9, 2019, Seoul, South Korea -Dr. Andrew Lees, Scientific Director of Fina BioSolutions LLC, gave a seminar today at IVI headquarters about the road towards affordable conjugate vaccines. During […]
DONATE